AstraZeneca's COVID vaccine slightly less effective against variant found in India, CEO tells FT - (London South East via NewsPoints Desk)

  • AstraZeneca CEO Pascal Soriot said the company's COVID-19 vaccine was only slightly less effective against the variant first found in India than the strain identified in Kent, as reported London South East on Friday.

  • He added the company is in talks with governments about new contracts for booster doses.

To read more NewsPoints articles, click here.